Found: 20
Select item for more details and to access through your institution.
Preserved SARS-CoV-2 Vaccine Cell-Mediated Immunogenicity in Patients With Inflammatory Bowel Disease on Immune-Modulating Therapies.
- Published in:
- Clinical & Translational Gastroenterology, 2022, v. 13, n. 4, p. e00484, doi. 10.14309/ctg.0000000000000484
- By:
- Publication type:
- Article
Case–control study of the association of chronic acid suppression and social determinants of health with COVID-19 infection.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-00367-7
- By:
- Publication type:
- Article
The ClC-2 Chloride Channel Activator, Lubiprostone, Improves Intestinal Barrier Function in Biopsies from Crohn's Disease but Not Ulcerative Colitis Patients.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 3, p. 811, doi. 10.3390/pharmaceutics15030811
- By:
- Publication type:
- Article
Evaluating the optimum number of biopsies to assess histological inflammation in ulcerative colitis: a retrospective cohort study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 10, p. 1574, doi. 10.1111/apt.16083
- By:
- Publication type:
- Article
Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 6, p. 1008, doi. 10.1111/apt.16026
- By:
- Publication type:
- Article
Letter: combination of biologics in inflammatory bowel diseases. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 3, p. 568, doi. 10.1111/apt.15919
- By:
- Publication type:
- Article
Automated spatial omics landscape analysis approach reveals novel tissue architectures in ulcerative colitis.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-68397-5
- By:
- Publication type:
- Article
Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 332, n. 11, p. 881, doi. 10.1001/jama.2024.12414
- By:
- Publication type:
- Article
Host engulfment pathway controls inflammation in inflammatory bowel disease.
- Published in:
- FEBS Journal, 2020, v. 287, n. 18, p. 3967, doi. 10.1111/febs.15236
- By:
- Publication type:
- Article
Heterogeneity and clonal relationships of adaptive immune cells in ulcerative colitis revealed by single-cell analyses.
- Published in:
- Science Immunology, 2020, v. 5, n. 50, p. 1, doi. 10.1126/sciimmunol.abb4432
- By:
- Publication type:
- Article
Early precursors and molecular determinants of tissue-resident memory CD8<sup>+</sup> T lymphocytes revealed by single-cell RNA sequencing.
- Published in:
- Science Immunology, 2020, v. 5, n. 47, p. 1, doi. 10.1126/sciimmunol.aaz6894
- By:
- Publication type:
- Article
Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Diarrhea in Patients with Inflammatory Bowel Diseases.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A gp130-Src-YAP module links inflammation to epithelial regeneration.
- Published in:
- Nature, 2015, v. 519, n. 7541, p. 57, doi. 10.1038/nature14228
- By:
- Publication type:
- Article
Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 11, p. 1031, doi. 10.1111/apt.15719
- By:
- Publication type:
- Article
Systematic review with meta‐analysis: association between vedolizumab trough concentration and clinical outcomes in patients with inflammatory bowel diseases.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 8, p. 848, doi. 10.1111/apt.15484
- By:
- Publication type:
- Article
Optimizing sequencing protocols for leaderboard metagenomics by combining long and short reads.
- Published in:
- Genome Biology, 2019, v. 20, n. 1, p. 1, doi. 10.1186/s13059-019-1834-9
- By:
- Publication type:
- Article
Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn's disease.
- Published in:
- Therapeutic Advances in Gastroenterology, 2020, v. 13, p. 1, doi. 10.1177/1756284820971214
- By:
- Publication type:
- Article
Risk of Relapse in Patients With Ulcerative Colitis With Persistent Endoscopic Healing: A Durable Treatment Endpoint.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 4, p. 567, doi. 10.1093/ecco-jcc/jjaa184
- By:
- Publication type:
- Article
Primary Non-Response to Tumor Necrosis Factor Antagonists is Associated with Inferior Response to Second-line Biologics in Patients with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis.
- Published in:
- Journal of Crohn's & Colitis, 2018, v. 12, n. 6, p. 635, doi. 10.1093/ecco-jcc/jjy004
- By:
- Publication type:
- Article
Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn's disease.
- Published in:
- Therapeutic Advances in Gastroenterology, 2020, v. 13, p. 1, doi. 10.1177/1756284820971214
- By:
- Publication type:
- Article